Genetic Biomarkers Of Sensitivity and Resistance to Venetoclax Monotherapy in Patients With Relapsed Acute Myeloid Leukemia
Am J Hematol
.
2018 May 17;93(8):E202-E205.
doi: 10.1002/ajh.25146.
Online ahead of print.
Authors
Brenda Chyla
1
,
Naval Daver
2
,
Kelly Doyle
1
,
Evelyn McKeegan
1
,
Xin Huang
1
,
Vivian Ruvolo
2
,
Zixing Wang
2
,
Ken Chen
2
,
Andrew Souers
1
,
Joel Leverson
1
,
Jalaja Potluri
1
,
Erwin Boghaert
1
,
Anahita Bhathena
1
,
Marina Konopleva
2
,
Relja Popovic
1
Affiliations
1
AbbVie, Inc., North Chicago, IL, USA.
2
MD Anderson Cancer Center, Houston, TX, USA.
PMID:
29770480
PMCID:
PMC6120451
DOI:
10.1002/ajh.25146
No abstract available
Keywords:
AML; BLC-2; Venetoclax.
Publication types
Letter